WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Eric Su
PeerJ Author
135 Points

Contributions by role

Author 135

Contributions by subject area

Bioinformatics
Clinical Trials
Drugs and Devices
Oncology
Statistics

Eric W Su

PeerJ Author

Summary

1984, BS, Biochemistry, Peking University
1991, PhD, Molecular Biology, University of California, Berkeley
1996, Post Doc, Dana Farber Cancer Institute, Harvard University

Biochemistry Bioinformatics Biotechnology Clinical Trials Computational Linguistics Data Mining & Machine Learning Data Science Drugs & Devices Molecular Biology Natural Language & Speech Statistics Visual Analytics

Work details

Principal Research Scientist

Eli Lilly and Company
October 1997
Advanced Analytics Hub

PeerJ Contributions

  • Articles 1
March 23, 2017
Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
Eric Wen Su, Todd M. Sanger
https://doi.org/10.7717/peerj.3154 PubMed 28348935